Table 4. ROC analysis results for potential markers and their combinations.
Classes | Potential markers/ combinations | Cel-miR-39 normalization | miR-222-3p normalization | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AUC | Optimal cut-of value (point) | Specificity | Sensitivity | Accuracy | AUC | Optimal cut-of value (point) | Specificity | Sensitivity | Accuracy | ||
Controls vs BC patients | miR-145-5p | 0.932 | 0.535 (−12.17) | 0.857 | 0.909 | 0.882 | 0.932 | 0.32 (−1.77) | 0.788 | 0.971 | 0.882 |
miR-16-5p | 0.664 | 0.51 (−4.45) | 0.606 | 0.686 | 0.647 | – | – | – | – | – | |
miR-191-5p | 0.868 | 0.60 (−9.00) | 0.939 | 0.714 | 0.824 | 0.904 | 0.421 (1.37) | 0.818 | 0.914 | 0.868 | |
miR-21-5p | 0.842 | 0.58 (−8.21) | 0.848 | 0.743 | 0.794 | 0.705 | 0.54 (2.42) | 0.848 | 0.714 | 0.779 | |
miR-210-3p | 0.713 | 0.55 (−13.86) | 0.758 | 0.657 | 0.706 | – | – | – | – | – | |
miR-222-3p | 0.760 | 0.549 (−10.57) | 0.879 | 0.657 | 0.765 | – | – | – | – | – | |
miR-29c-3p | 0.739 | 0.68 (−15.23) | 0.970 | 0.457 | 0.706 | – | – | – | – | – | |
miR-145-5p + miR-191-5p | 0.930 | 0.52 | 0.879 | 0.886 | 0.882 | 0.984 | 0.72 | 1.000 | 0.943 | 0.971 | |
miR-145-5p + miR-21-5p | 0.936 | 0.44 | 0.818 | 0.943 | 0.882 | 0.932 | 0.44 | 0.818 | 0.914 | 0.868 | |
miR-191-5p + miR-21-5p | 0.875 | 0.36 | 0.697 | 0.914 | 0.809 | 0.919 | 0.53 | 0.879 | 0.857 | 0.868 | |
miR-145-5p + miR-191-5p + miR-21-5p | 0.933 | 0.605 | 0.939 | 0.829 | 0.882 | 0.984 | 0.72 | 1.000 | 0.943 | 0.971 | |
HER2- vs HER2+ | miR-145-5p | – | – | – | – | – | 0.751 | 0.15 (−0.98) | 0.481 | 1.000 | 0.588 |
miR-191-5p | – | – | – | – | – | 0.831 | 0.147 (1.98) | 0.667 | 1.000 | 0.735 | |
Ki-67: <20% vs ≥20% | miR-21-5p | – | – | – | – | – | 0.791 | 0.506 (2.55) | 0.706 | 0.944 | 0.829 |
Tumor grade: G2 vs G3 | miR-145-5p | – | – | – | – | – | 0.780 | 0.32 (−0.25) | 0.667 | 0.964 | 0.912 |
miR-210-3p | – | – | – | – | – | 0.845 | 0.10 (−3.73) | 1.000 | 0.679 | 0.735 |